FilingSEC EDGAR8-K
Polaryx Therapeutics Announces Annual Meeting Results
· SEC accepted
StageAnnual Meeting Completed
Filing content
At the annual meeting held on September 10, 2026, shareholders approved the election of Class I directors and the appointment of the independent registered public accounting firm.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…